1Yoshida S, Yoshida A, Matsui H, et al. Involvement of ma- crophage chemotaclic protein-1 and interleukin-1 beta during inflammatory but not basic fibroblast growth factor-depen- dent neovascularization in the mouse cornea[J]. Lab Invest, 2003, 83(7):927-938.
2Kruse F E, Joussen A M, Rohrschneider K, et al. Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor[J]. Graefes Arch Clin Exp Ophthalmol, 1998, 236(6):461-466.
5Kenyon B M, Voest E E, Chen C C, et al. A model of angio- genesis in the mouse cornea [J].Invest Ophthalmol Vis Sci, 1996, 37(8):1625-1632.
6Pola R, Gaetani E, Flex A, et al. Comparative analysis of the invivo angiogenic properties of stable prostacyclin analogs a possible role for peroxisome proliferator-activated receptors [J]. J Mol Cell Cardiol, 2004, 36(3):363-370.
8O' Reilly M S, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994, 79(21): 315-328.
10Bae S R, Park C, Choi J C, et al. Effects of ultra high molecular weight poly-Y-glutamic acid from (chungkookjang) on corneal wound healing[J]. J Microbiol Biotechnol, 2010, 20(4):803-808.
9Yamada J,Dana MR,Sotozono C,et al.Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury[J].Exp Eye Res,2003,76(2):161-167.
10O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin:a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J].Cell,1994,79(21):315-328.
